[Human thrombin inhibitors (  2 -macroglobulin and antithrombin 3) during and after surgical and gynecologic-obstetrical intervention].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000991:Antithrombins / Q000378:metabolism*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D006330:Heart Defects, Congenital / Q000601:surgery; D006355:Heart-Lung Machine; D006470:Hemorrhage / Q000503:physiopathology; D006801:Humans; D008259:Macroglobulins / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000378:metabolism; D011247:Pregnancy; D011248:Pregnancy Complications / Q000601:surgery; D011480:Protease Inhibitors; D013514:Surgical Procedures, Operative; D013917:Thrombin / Q000037:antagonists & inhibitors*; D014361:Trypsin Inhibitors / Q000378:metabolism
D000991:Antithrombins; D008259:Macroglobulins; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D005340:Fibrinogen; D010958:Plasminogen; D013917:Thrombin; D005341:Fibrinolysin
Verhalten menschlicher Thrombininhibitoren (  2 -Makroglobulin und Antithrombin 3) während und nach chirurgischen und gynäkologisch-geburtshilflichen Eingriffen.